In conclusion, our findings identify that DEX can suppress the proliferation and facilitate apoptosis of HCC cells via upregulating miR-130a and inhibiting EGR1 expression, thus offering a new target for the treatment of HCC. This evidence concerns the gene EGR1 and hepatocellular carcinoma.